Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial to Evaluate the Efficacy and Safety of a Single Treatment of DaxibotulinumtoxinA for Injection in Adults with Isolated Cervical Dystonia (ASPEN-1)
Clinical Trial Grant
Administered By
Neurology, Neuromuscular Disease
Awarded By
Revance Therapeutics Inc.
Start Date
January 18, 2019
End Date
July 1, 2021
Administered By
Neurology, Neuromuscular Disease
Awarded By
Revance Therapeutics Inc.
Start Date
January 18, 2019
End Date
July 1, 2021